|
SFXN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.304400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.921000E-01 |
| Normal-vs-Stage2 |
8.006800E-01 |
| Normal-vs-Stage3 |
3.685200E-01 |
| Normal-vs-Stage4 |
2.045000E-01 |
| Stage1-vs-Stage2 |
6.953000E-01 |
| Stage1-vs-Stage3 |
4.469500E-02 |
| Stage1-vs-Stage4 |
2.600400E-02 |
| Stage2-vs-Stage3 |
2.997800E-01 |
| Stage2-vs-Stage4 |
1.923400E-01 |
| Stage3-vs-Stage4 |
6.460000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.633200E-01 |
| Normal-vs-AfricanAmerican |
5.166400E-02 |
| Normal-vs-Asian |
9.430200E-01 |
| Caucasian-vs-AfricanAmerican |
1.262300E-02 |
| Caucasian-vs-Asian |
9.153200E-01 |
| AfricanAmerican-vs-Asian |
3.826400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.307600E-01 |
| Normal-vs-Female |
2.797400E-01 |
| Male-vs-Female |
1.758230E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.452500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.188400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.120200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.231400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.095690E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.895800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.020500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.934800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.902200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.105360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.708390E-01 |
| Normal-vs-Grade 2 |
3.764800E-01 |
| Normal-vs-Grade 3 |
9.782800E-01 |
| Normal-vs-Grade 4 |
4.637100E-03 |
| Grade 1-vs-Grade 2 |
4.839600E-01 |
| Grade 1-vs-Grade 3 |
1.818580E-01 |
| Grade 1-vs-Grade 4 |
3.976400E-03 |
| Grade 2-vs-Grade 3 |
2.593600E-01 |
| Grade 2-vs-Grade 4 |
7.52130000000184E-05 |
| Grade 3-vs-Grade 4 |
1.319030E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.756770E-03 |
| Normal-vs-ccB subtype |
3.568200E-02 |
| ccA subtype-vs-ccB subtype |
1.08910003238094E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.607600E-01 |
| Normal-vs-N1 |
6.986400E-01 |
| N0-vs-N1 |
6.282000E-01 |
|
|
